BRAVENKnow what's real. Now.
Wednesday, August 19, 2026
● ImportantWorld10 outlets covering this

Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning

First publishedAug 19, 10:49 UTC
Last updatedAug 19, 17:13 UTC · 12m ago
11 outletCNBC Top News33 outletsInvesting.com · Stock Market, MarketWatch11 outletNBC News11 outletTIME33 outletsNYT Home, The Hill, CBS News11 outletSeattle Times
CNBC Top News7Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trialOpen ↗Investing.com · Stock Market6Moderna shares surge as melanoma vaccine with Merck succeeds in large trialOpen ↗Investing.com · Stock Market6Moderna shares soar over 90% on melanoma drug trial successOpen ↗MarketWatch7Moderna’s stock doubles on promising cancer-vaccine resultsOpen ↗NBC News8Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanomaOpen ↗TIME7Promising Results for mRNA Cancer Vaccine from Moderna and MerckOpen ↗NYT Home9Moderna, Merck Say mRNA Vaccine Prevents Melanoma From ReturningOpen ↗The Hill7Moderna, Merck mRNA cancer vaccine prevents melanoma from returningOpen ↗CBS News8Moderna stock surges as melanoma vaccine trial shows "landmark moment"Open ↗Seattle Times6Moderna shares surge after it says its experimental mRNA cancer treatment passed a key testOpen ↗
10 outlets over time — hover a bar for its window & outletslast updated
Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning - image 1Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning - image 2Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning - image 3Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning - image 4Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning - image 5Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning - image 6Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning - image 7Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning - image 8
1 / 8
● Story signals

How strong is this topic?

9.0/10Significanceimpact & urgency
7.1/10Source trustoutlet authority
10Outletsindependent sources

Significance weighs impact, urgency & coverage breadth · Source trust is the outlets' average authority · more outlets means a more confirmed story.

Answer

Cancer vaccine research in the lab at the Moderna Inc. headquarters in Cambridge, Mass.

Reported by 10 outlets — NYT Home, CBS News, NBC News, The Hill, TIME, and 4 more. See all sources ↓

Read the full report at NYT Home ↗

Why it matters

10 outlets are covering this world story — one to watch as reporting develops.

In brief
What's the story?
Cancer vaccine research in the lab at the Moderna Inc. headquarters in Cambridge, Mass.
How widely is it covered?
10 outlets, average source rating 7.1/10.
When was it last updated?
12m ago.
Different angles across outlets
Coverage map

How outlets are framing the same story

Here's how each outlet is covering the story — compare their headlines and timing at a glance.

  • Coverage card9 outlets
    1Coverage
    Scouting report

    Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial

    Sources9
    TypeCoverage
    NYT Home
    CBS News
    NBC News
    The Hill
    TIME
    MarketWatch
    CNBC Top News
    Seattle Times
    Investing.com · Stock Market
Related in the knowledge graph
organizationMerck SayorganizationModerna Inc
Sources (10)
Avg source rating 7.1/10
Processing cluster
A1A2A3B1B2B3
Share this article
X / TwitterLinkedInWhatsApp
Summarize with AI (opens AI chat with article URL · Gemini: prompt copied to clipboard)
GPTPerplexityGeminiClaude